Chondromodulin-I (319-327)

Chondromodulin-I (319-327) is a synthetic peptide fragment derived from the C-terminal region of the native Chondromodulin-I protein, a glycoprotein recognized for its regulatory roles in cartilage matrix maintenance and angiogenesis inhibition. The 319-327 segment represents a specific bioactive domain, making it a valuable tool for dissecting the structure-function relationships of Chondromodulin-I in extracellular matrix biology. Its defined sequence enables targeted studies on cartilage homeostasis, tissue engineering, and the molecular mechanisms underlying cartilage-specific signaling pathways. Researchers utilize this peptide to investigate the biochemical interactions and physiological effects mediated by distinct Chondromodulin-I fragments, supporting advancements in musculoskeletal and connective tissue research.

Cartilage biology research: As a defined peptide fragment, Chondromodulin-I (319-327) is widely employed to elucidate the molecular pathways governing cartilage development, differentiation, and maintenance. By introducing this segment into in vitro chondrocyte cultures or ex vivo cartilage explants, scientists can probe its influence on cell proliferation, extracellular matrix production, and gene expression relevant to cartilage-specific markers. Such studies provide critical insights into how discrete Chondromodulin-I domains contribute to cartilage integrity and may help clarify the peptide's role in modulating chondrogenic activity at the cellular and molecular levels.

Angiogenesis inhibition studies: The native Chondromodulin-I protein is a well-documented endogenous inhibitor of angiogenesis within avascular tissues such as cartilage. The 319-327 peptide fragment offers a focused approach to dissecting the anti-angiogenic properties of the protein by allowing researchers to assess its effects on endothelial cell migration, tube formation, and vascularization in controlled experimental models. Utilizing this fragment in endothelial cell assays or co-culture systems facilitates mechanistic exploration of the molecular determinants that restrict vascular invasion into cartilage and other specialized matrices.

Peptide structure-function analysis: The Chondromodulin-I (319-327) peptide serves as a precise molecular probe for structure-activity relationship (SAR) studies. By comparing the bioactivity of this segment with other Chondromodulin-I-derived peptides, researchers can map functional epitopes and determine which residues are critical for biological activity. Such SAR investigations are instrumental for identifying minimal functional domains, optimizing peptide design, and developing analogs with enhanced stability or specificity for downstream applications in biomaterials or tissue engineering.

Biomaterials and tissue engineering: In the context of scaffold design and regenerative strategies, the 319-327 peptide fragment is incorporated into biomaterials to modulate cellular responses and matrix interactions. By functionalizing hydrogels, membranes, or three-dimensional scaffolds with this peptide, researchers aim to recapitulate aspects of the native cartilage microenvironment, promoting chondrocyte viability while inhibiting unwanted vascularization. These applications are particularly relevant for the development of advanced cartilage repair constructs and for studying the role of specific matrix signals in tissue regeneration.

Analytical and detection tool: The defined sequence of Chondromodulin-I (319-327) enables its use as a standard or positive control in analytical assays designed to detect or quantify Chondromodulin-I-related activity. It can be utilized in immunoassays, binding studies, or peptide-based detection platforms to calibrate responses, validate antibody specificity, or benchmark functional assays. This application supports the development and standardization of research protocols investigating Chondromodulin-I function across diverse experimental systems.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

3. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells